Collecting Medical Information and Tissue Samples from Patients with Pancreatic Cancer or Other Pancreatic Disorders

Overview

About this study

The purpose of this study is to develop a panel of primary care controls to be used to compare the pancreatic disease patients who are recruited into the ongoing IRB protocol 354-06.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Appointment for a general health examination , resident of the US or Canada.
Mentally competent.
Age >18

Exclusion Criteria:

Unable to understand English or unable to complete informed consent form.
Prior history of cancer (except non-melanoma skin cancer); intraductal papillary mucinous tumors (IPMT), intraductal papillary mucinous neoplasia (IPMN), islet cell tumor or neuroendocrine cancer, or hereditary, chronic, or acute pancreatitis.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status	Contact
Rochester, Minn. Mayo Clinic principal investigator Shounak Majumder, M.D.	Closed for enrollment	Contact information: Adriana Delgado M.A., CCRP (507) 422-5001 Delgado.Adriana@mayo.edu

Mayo Clinic Location

Status

Contact

Rochester, Minn.

Mayo Clinic principal investigator

Shounak Majumder, M.D.

Closed for enrollment

Contact information:

Adriana Delgado M.A., CCRP

(507) 422-5001

Delgado.Adriana@mayo.edu

More information

Publications

Publications are currently not available

Clinical Trials